News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer
Deridre Kelly/X
Nov 2, 2024, 19:05

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer

Deridre Kelly, Medical Oncologist at Mater Misericordiae University Hospital, shared a post on X:

“Immuno Oncology: Anti–PD-L1 and TKI in anaplastic thyroid cancer.

Median OS: 19 mosBRAF V600E-mutated patients: 43 mos (50% ORR)
Longest OS in ATC history!

Targeted and immunotherapy synergy outcomes.”

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer

cancer Deridre Kelly immuno-oncology JAMA Oncology Maria Cabanillas OncoDaily Oncology thyroid cancer
Special Coverage
Insight
Nov 2, 2024, 19:05
Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer
Blog
Nov 2, 2024, 19:02
Contribute to your field of research by becoming a reviewer - Sage Journals
Blog
Nov 2, 2024, 18:58
Defining Opportunities to Improve Women’s Health in LMICs: The Every Woman Study - London Global Cancer Week
Blog
Nov 2, 2024, 18:51
Gregg Margolis: Three things to read about health policy this week
Blog
Nov 2, 2024, 18:47
Razelle Kurzrock: Privileged to honor 2 visionaries a few years ago
Blog
Nov 2, 2024, 18:46
For the love of tomorrow, remind your friend and family members to get screened - American Cancer Society
Insight
Nov 2, 2024, 18:42
Integrative Medicine in Oncology: Redefining the Standard of Care - Society for Integrative Oncology
Blog
Nov 2, 2024, 18:11
Regional and global experts to update cancer treatment guidelines for Sub-Saharan Africa - National Comprehensive Cancer Network
Blog
Nov 2, 2024, 17:53
Last chance to register for ESMO Asia 2024 at discounted rates
Blog
Nov 2, 2024, 17:41
Join Childhood Cancer International - Europe at the smartCARE
Blog
Nov 2, 2024, 17:40
Min-Han Tan: More US cancer patients can now benefit from non-invasive ctDNA and ctRNA liquid biopsies
Blog
Nov 2, 2024, 17:38
Dr Hans Henri P. Kluge nominated for a second term as WHO Regional Director at the RC74